Profile
Corporate information
Registration country
Registration country
Investment activity status
Active investor
Company type
Academic institutionInvestments
Selected investments
| Company | Country | Notes | ||
|---|---|---|---|---|
|
Tolerx Inc Developer of a novel therapies focusing on modulating T-cell activities for treating autoimmune diseases, diabetes, and cancer. |
United States | N/A |